Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Randomized study in people · 2016
- What was studied
- Stroke patients receiving standardized rehabilitation; CARS trial
- Main finding
- The exploratory trial reports better upper-limb motor recovery at day 90.
Action Research Arm Test at day 90 · Mann–Whitney estimator 0.71; 95% CI 0.63–0.79 · p<0.0001
Reported findings and study design
CARS: randomized double-blind placebo comparison in early stroke rehabilitation. Cerebrolysin 30 mL/day for 21 days, starting 24–72 hours after stroke; rehabilitation for 21 days.
Population or model Stroke patients receiving standardized rehabilitation; CARS trial
Dose, route and schedule
Cerebrolysin: 30 mL once daily for 21 days, beginning 24–72 hours after stroke onset, alongside a standardized rehabilitation program. The indexed abstract does not specify the route.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Action Research Arm Test at day 90 | Mann–Whitney estimator 0.71; 95% CI 0.63–0.79 | p<0.0001 |
| Global status across 12 outcome scales | Mann–Whitney estimator 0.62; 95% CI 0.58–0.65 | p<0.0001 |
| Premature discontinuation | 3.8% |
These are nonparametric effect-size estimators, not 71% or 62% improvements. Authors describe the trial as exploratory; the indexed abstract does not state the sample size.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Authors call for a larger confirmatory trial. Rehabilitation and timing define the setting; this is not evidence of healthy-person enhancement.
Source details
Journal publication
Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.
Sources checked
Citation
Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke
Study source ↗ · DOI 10.1161/strokeaha.115.009416 · Bibliography entry · Link to this summary